Alpha 2.0
Login Register
» Articles » PMID: 33764031

PSMA PET/CT to Stage High-risk Prostate Cancer: is Already the Time to Replace Conventional Imaging?

Overview
Journal Minerva Urol Nephrol
Specialties Nephrology
Urology
Date 2021 Mar 25
PMID 33764031
Citations 2
Authors
Riccardo Schiavina
Lorenzo Bianchi
Eugenio Bunocilla
Affiliations
Soon will be listed here.
Citing Articles

Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection.

Droghetti M, Bianchi L, Presutti M, Vetrone L, Farolfi A, Mei R Front Oncol. 2024; 14:1324631.

PMID: 38807770 PMC: 11130476. DOI: 10.3389/fonc.2024.1324631.

PSMA PET in Imaging Prostate Cancer.

Tsechelidis I, Vrachimis A Front Oncol. 2022; 12:831429.

PMID: 35155262 PMC: 8832487. DOI: 10.3389/fonc.2022.831429.